evolcSign inStart free
Menu

Sartar Therapeutics

Develops targeted cancer therapies for patients with gastrointestinal stromal tumours and other cancers

Helsinki, FinlandFounded 2016sartartherapeutics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Sartar Therapeutics

Sartar Therapeutics develops targeted therapies for hard-to-treat cancers. Its investigational drug SAR003 targets cancers expressing the PDE3A gene and is initially being developed for gastrointestinal stromal tumours (GIST).

SAR003 is a long-acting formulation of anagrelide that acts as a molecular glue. The company is studying it as both a monotherapy and in combination with other cancer drugs, and has reported preclinical proof-of-concept results.

SAR003 has orphan drug designations from the European Medicines Agency and the US Food and Drug Administration for GIST. Sartar was founded in 2016 and is headquartered in Helsinki, Finland.

Product: SAR003 is an investigational targeted therapy for PDE3A-expressing cancers, initially being developed for gastrointestinal stromal tumours.

Jobs at Sartar Therapeutics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Scaffdex

    Finnish maker of the RegJoint bioresorbable small-joint implant and CellCrown cell culture inserts for clinicians and researchers
    Tampere, FinlandBiotech & pharmaFounded 2006
    New on Evolc

  • SCellex

    Spatial and bulk 3' RNA-seq tools and services for single-cell gene expression research in biotech and life sciences
    Helsinki, FinlandBiotech & pharmaFounded 2018
    New on Evolc

  • SpringDNA

    Environmental DNA sampling and laboratory analysis for biodiversity monitoring and impact assessments
    Helsinki, FinlandBiotech & pharmaFounded 2026
    Young companyNew on Evolc

  • Suomen Lääkekehityskeskus

    State-owned Finnish company that helps university researchers take drug compounds from early discovery to clinical studies
    Turku, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc

  • SwitchPoint Bio

    Epigenomics and AI platform for biopharma and clinical research teams developing biomarkers and stratifying patients
    Helsinki, FinlandBiotech & pharmaFounded 2025
    Young companyNew on Evolc

  • Symeres Finland

    Preclinical ADME-Tox research services for pharmaceutical and biotechnology companies
    Oulu, FinlandBiotech & pharmaFounded 20111 open job
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • PHP
  • WordPress
  • nginx